Up a level |
Number of items: 1.
Eyre, Toby A, Hildyard, Catherine, Hamblin, Angela, Ali, Ayesha S, Houlton, Aimee, Hopkins, Louise, Royston, Daniel, Linton, Kim M, Pettitt, Andrew, Rule, Simon et al (show 11 more authors)
(2019)
A phase II study to assess the safety and efficacy of the dual mTORC1/2 inhibitor vistusertib in relapsed, refractory DLBCL.
HEMATOLOGICAL ONCOLOGY, 37 (4).
pp. 352-359.